
Robeauté is a neurosurgical microrobotics company developing a modular medical device designed around a universal robotic core with interchangeable micro-extensions. This platform is engineered to diagnose, treat, and monitor the brain with high flexibility and precision, adapting to various clinical applications such as tissue sampling, targeted therapy delivery, electrode implantation, and real-time data collection from deep within the brain. The company, founded by Bertrand Duplat and Joana Cartocci, aims to transform neurosurgery by integrating robotics, physics, material science, chemistry, biology, and medicine. Robeauté has received significant press coverage, including features in The Independent, BloombergTV, and Fortune, and has won several innovation awards.

Robeauté is a neurosurgical microrobotics company developing a modular medical device designed around a universal robotic core with interchangeable micro-extensions. This platform is engineered to diagnose, treat, and monitor the brain with high flexibility and precision, adapting to various clinical applications such as tissue sampling, targeted therapy delivery, electrode implantation, and real-time data collection from deep within the brain. The company, founded by Bertrand Duplat and Joana Cartocci, aims to transform neurosurgery by integrating robotics, physics, material science, chemistry, biology, and medicine. Robeauté has received significant press coverage, including features in The Independent, BloombergTV, and Fortune, and has won several innovation awards.
What they do: Develop modular neurosurgical microrobots for diagnosis, treatment, and monitoring inside the brain
Headquarters: Paris, Île-de-France, France
Founders / leadership: Bertrand Duplat (Founder & CEO); Joana Cartocci (Founder & COO)
Latest disclosed funding: $28,000,000 (announced Jan 2025; additional grant activity Feb 17, 2025)
Employee count: 33
Minimally invasive neurosurgery; intracerebral diagnosis, targeted therapy, monitoring, and electrode implantation.
Medtech / Medical Devices
$28,000,000
Announced financing reported January 2025
Funding activity reported on Feb 17, 2025 tied to grant and venture entries
“Investors reported to have participated include LocalGlobe, Kindred Ventures, Cherry Ventures, Plural Platform, APEX Ventures, and BrainLAB”